| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_291fa187e998635ac3b93c9a77a1f28d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a0894a006d4569e0330baedef46356a1 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-185 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-18 |
| filingDate |
2004-02-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_967bd1e8bcabaae166228ff4651a78a2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_897a5323db2d56717e715cc3f8e6c344
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_71f76e5eba82a121be1d6dc7acb851eb |
| publicationDate |
2006-02-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-1622636-A2 |
| titleOfInvention |
Use of intraputaminal infused glial cell-line derived neurotrophic factor in the treatment of parkinson's disease in humans |
| abstract |
A method of treating Parkinson's disease in humans is disclosed, wherein glial cell-line derive neurotrophic factor (GDNF) is chronically administered directly to one or both putamen of a human in need of treatment thereof. In one aspect of the present invention the GDNF is infused directly into one or both putamen through one or more indwelling intraparenchymal brain catheters connected to an implantable pump. |
| priorityDate |
2003-02-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |